Suggestions
Share
Journal Information
Vol. 43. Issue 2.
Pages 129 (February 2007)
Letters to the Editor
Full text access
Development of Extrapulmonary Tuberculosis
Visits
4255
Iván Landiresa, Virginia Núñez-Samudiob, Erick Landiresb
a Gorgas Memorial Institute of Health Studies, Panamá, Panama
b Centro Integral de Radiodiagnóstico, Chitré, Panama
This item has received
Article information
Full text is only available in PDF
REFERENCES
[1]
ZM Fuentes, JA Caminero.
Controversias en el tratamiento de la tuberculosis extrapulmo-nar.
Arch Bronconeumol, 42 (2006), pp. 194-201
[2]
PJ Cardona.
Mycobacterium tuberculosis y Homo sapiens, un largo camino reconido y por recorrer.
Med Clin (Bare), 126 (2006), pp. 771-773
[3]
BR Bloom, PM Small.
The evolving relation between humans and Mycobacterium tuberculosis..
N Engl J Med, 338 (1998), pp. 677-678
[4]
L Tsenova, B Mangaliso, G Muller, et al.
Use of IM1D3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.
Antimicrob Agents Chemother, 46 (2002), pp. 1887-1895
[5]
P Selvaraj, U Sriram, S Mathan Kurian.
Tumour necrosis factor alpha (−238 and −308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLAA, B, and DR genes.
Tuberculosis (Edinb), 81 (2001), pp. 335-341
[6]
A Baena, JY Ieung, AD Sullivan, et al.
TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry.
Genes Immun, 3 (2002), pp. 482-487
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools